InVivoMAb Anti-Campylobacter jejuni subsp. wlaB/pglK Nanobody (Iv0202) (JN929010)

Name: InVivoMAb Anti-Campylobacter jejuni subsp. wlaB/pglK Nanobody (Iv0202)
Brand: abinScience
SKU: JN929010
Price: 370 USD
Availability: InStock

Fiche technique Partager le produit Copier les informations

Prix(USD) :

Spécification :

100ug
1mg

Nombre :

Contactez-nous

Aperçu
Images
Reférences
Fiche technique
SDS

Aperçu

Numéro de catalogue	JN929010
Description	InVivoMAb Anti-Campylobacter jejuni subsp. wlaB/pglK Nanobody (Iv0202) [Iv0202] (JN929010) is a alpaca monoclonal antibody detecting Protein glycosylation K in ELISA, Neutralization.
Reactivité des espèces	Campylobacter jejuni
Applications	ELISA, Neutralization
Espèce hôte	Alpaca
Clonalité	Monoclonal
Isotype	VHH-8His-Cys-tag
ID de clone	Iv0202
Cible	Protein glycosylation K, 7.5.2.5, pglK, wlaB, Cj1130c
Niveau d'endotoxines	<0.01 EU/ug
Pureté	>95% as determined by SDS-PAGE.
Produits associés	pH 7.4 Dilution Buffer
Purification	Purified by Nickel column.
Numéro d'accès	Q0P9C4
Forme	Liquid
Tampon de stockage	0.01M PBS pH 7.4 Reférez-vous aux informations spécifiques sur le tampon dans la copie papier du datasheet ou dans le COA spécifique au lot.
Stabilité et stockage	Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Contexte	Protein glycosylation K (wlaB/pglK) is a ~64 kDa protein. Mediates the ATP-dependent translocation of the undecaprenylpyrophosphate-linked heptasaccharide intermediate across the cell membrane; this is an essential step during the N-linked protein glycosylation pathway. Transport across the membrane is effected via ATP-driven conformation changes. Most likely, only the polar and charged part of the glycolipid enter the substrate-binding cavity, and the lipid tail remains exposed to the membrane lipids during the transmembrane flipping process.
Note	For research use only. Not suitable for clinical or therapeutic use.

Images

SDS-PAGE

SDS-PAGE for InVivoMAb Anti-Campylobacter jejuni subsp. wlaB/pglK Nanobody (Iv0202).

Reférences

Fiche technique

InVivoMAb Anti-Campylobacter jejuni subsp. wlaB/pglK Nanobody (Iv0202).pdf

Download SDS PDF

Formula

Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)

Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.

Mass

Concentration

Volume

Molecular Weight *

g/mol

Formula

C₁ × V₁ = C₂ × V₂

Enter any 3 of the 4 values to solve for the unknown.

Stock Solution

C₁ (Stock Conc.)

V₁ (Stock Vol.)

Working Solution

C₂ (Working Conc.)

V₂ (Working Vol.)

Protéines Recombinantes

Anticorps

Kits d'Essai